Cellular And Gene Therapy Trial Design: Draft Guidance Highlights Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA provides advice on designing early-phase trials to assess safety, tolerability and feasibility of administering cellular therapy and gene therapy products but stresses the unique risks of these products.